These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 30644318)
21. Selection of a GPER1 Ligand via Ligand-based Virtual Screening Coupled to Molecular Dynamics Simulations and Its Anti-proliferative Effects on Breast Cancer Cells. Martínez-Muñoz A; Prestegui-Martel B; Méndez-Luna D; Fragoso-Vázquez MJ; García-Sánchez JR; Bello M; Martínez-Archundia M; Chávez-Blanco A; Dueñas-González A; Mendoza-Lujambio I; Trujillo-Ferrara J; Correa-Basurto J Anticancer Agents Med Chem; 2018; 18(11):1629-1638. PubMed ID: 29745344 [TBL] [Abstract][Full Text] [Related]
22. New Quinoline Based Sulfonamide Derivatives: Cytotoxic and Apoptotic Activity Evaluation Against Pancreatic Cancer Cells. Yurttaş L; Çiftçi GA Anticancer Agents Med Chem; 2018; 18(8):1122-1130. PubMed ID: 29521252 [TBL] [Abstract][Full Text] [Related]
23. Synthesis and antiproliferative activity of amino-substituted benzimidazo[1,2-α]quinolines as mesylate salts designed by 3D-QSAR analysis. Vušak D; Perin N; Martin-Kleiner I; Kralj M; Karminski-Zamola G; Hranjec M; Bertoša B Mol Divers; 2017 Aug; 21(3):621-636. PubMed ID: 28667495 [TBL] [Abstract][Full Text] [Related]
24. Discovery of 1-benzoyl-3-cyanopyrrolo[1,2-a]quinolines as a new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assay. Part 1: Structure-activity relationships of the 1- and 3-positions. Kemnitzer W; Kuemmerle J; Jiang S; Zhang HZ; Sirisoma N; Kasibhatla S; Crogan-Grundy C; Tseng B; Drewe J; Cai SX Bioorg Med Chem Lett; 2008 Dec; 18(23):6259-64. PubMed ID: 18952423 [TBL] [Abstract][Full Text] [Related]
26. Design, synthesis, and structure-activity relationships of novel 6,7-disubstituted-4-phenoxyquinoline derivatives as potential antitumor agents. Tang Q; Zhao Y; Du X; Chong L; Gong P; Guo C Eur J Med Chem; 2013 Nov; 69():77-89. PubMed ID: 24012712 [TBL] [Abstract][Full Text] [Related]
27. Design and synthesis of new RAF kinase-inhibiting antiproliferative quinoline derivatives. Part 2: Diarylurea derivatives. El-Gamal MI; Khan MA; Tarazi H; Abdel-Maksoud MS; Gamal El-Din MM; Yoo KH; Oh CH Eur J Med Chem; 2017 Feb; 127():413-423. PubMed ID: 28088086 [TBL] [Abstract][Full Text] [Related]
28. Novel purine thioglycoside analogs: synthesis, nanoformulation and biological evaluation in in vitro human liver and breast cancer models. Abu-Zaied MA; Loutfy SA; Hassan AE; Elgemeie GH Drug Des Devel Ther; 2019; 13():2437-2457. PubMed ID: 31440030 [No Abstract] [Full Text] [Related]
29. Synthesis of novel substituted purine derivatives and identification of the cell death mechanism. Demir Z; Guven EB; Ozbey S; Kazak C; Atalay RC; Tuncbilek M Eur J Med Chem; 2015 Jan; 89():701-20. PubMed ID: 25462277 [TBL] [Abstract][Full Text] [Related]
30. Design, synthesis and antibreast cancer MCF-7 cells biological evaluation of heterocyclic analogs of resveratrol. Du C; Dong MH; Ren YJ; Jin L; Xu C J Asian Nat Prod Res; 2017 Sep; 19(9):890-902. PubMed ID: 27809606 [TBL] [Abstract][Full Text] [Related]
31. Design, synthesis, antiproliferative activity and docking studies of quinazoline derivatives bearing 2,3-dihydro-indole or 1,2,3,4-tetrahydroquinoline as potential EGFR inhibitors. OuYang Y; Zou W; Peng L; Yang Z; Tang Q; Chen M; Jia S; Zhang H; Lan Z; Zheng P; Zhu W Eur J Med Chem; 2018 Jun; 154():29-43. PubMed ID: 29775935 [TBL] [Abstract][Full Text] [Related]
32. Quinoline-3-Carboxylic Acids: A Step Toward Highly Selective Antiproliferative Agent. Mittal RK; Purohit P Anticancer Agents Med Chem; 2021; 21(13):1708-1716. PubMed ID: 33238852 [TBL] [Abstract][Full Text] [Related]
33. Synthesis and antiproliferative evaluation of 6-aryl-11-iminoindeno[1,2-c]quinoline derivatives. Tseng CH; Tzeng CC; Chung KY; Kao CL; Hsu CY; Cheng CM; Huang KS; Chen YL Bioorg Med Chem; 2011 Dec; 19(24):7653-63. PubMed ID: 22079254 [TBL] [Abstract][Full Text] [Related]
34. Investigating the antiproliferative activity of quinoline-5,8-diones and styrylquinolinecarboxylic acids on tumor cell lines. Podeszwa B; Niedbala H; Polanski J; Musiol R; Tabak D; Finster J; Serafin K; Milczarek M; Wietrzyk J; Boryczka S; Mol W; Jampilek J; Dohnal J; Kalinowski DS; Richardson DR Bioorg Med Chem Lett; 2007 Nov; 17(22):6138-41. PubMed ID: 17904844 [TBL] [Abstract][Full Text] [Related]
35. Discovery of 9H-purins as potential tubulin polymerization inhibitors: Synthesis, biological evaluation and structure-activity relationships. Zhou ZZ; Shi XD; Feng HF; Cheng YF; Wang HT; Xu JP Eur J Med Chem; 2017 Sep; 138():1126-1134. PubMed ID: 28763647 [TBL] [Abstract][Full Text] [Related]
36. Design and synthesis of 4-piperazinyl quinoline derived urea/thioureas for anti-breast cancer activity by a hybrid pharmacophore approach. Viswas RS; Pundir S; Lee H J Enzyme Inhib Med Chem; 2019 Dec; 34(1):620-630. PubMed ID: 30727782 [TBL] [Abstract][Full Text] [Related]
37. Synthesis and antiproliferative evaluations of certain 2-phenylvinylquinoline (2-styrylquinoline) and 2-furanylvinylquinoline derivatives. Chang FS; Chen W; Wang C; Tzeng CC; Chen YL Bioorg Med Chem; 2010 Jan; 18(1):124-33. PubMed ID: 19944612 [TBL] [Abstract][Full Text] [Related]
38. Purines and triazolo[4,3-e]purines containing pyrazole moiety as potential anticancer and antioxidant agents. Shaaban OG; Abd El Razik HA; A Shams El-Dine SE; Ashour FA; El-Tombary AA; Afifi OS; Abu-Serie MM Future Med Chem; 2018 Jun; 10(12):1449-1464. PubMed ID: 29788781 [TBL] [Abstract][Full Text] [Related]
39. Design, synthesis and biological evaluation of 4-anilinoquinoline derivatives as novel potent tubulin depolymerization agents. Zhou Y; Yan W; Cao D; Shao M; Li D; Wang F; Yang Z; Chen Y; He L; Wang T; Shen M; Chen L Eur J Med Chem; 2017 Sep; 138():1114-1125. PubMed ID: 28763646 [TBL] [Abstract][Full Text] [Related]
40. 4-Phenyl quinoline derivatives as potential serotonin receptor ligands with antiproliferative activity. Joshi PV; Sayed AA; RaviKumar A; Puranik VG; Zinjarde SS Eur J Med Chem; 2017 Aug; 136():246-258. PubMed ID: 28499170 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]